Pulmatrix Inc Earnings
The next earnings date for Pulmatrix Inc is October 15, 2026.
They are scheduled to announce earnings after the market closes that day.
Analyst Estimates of Pulmatrix Inc Earnings
| No results. | |
What is an Earnings Date
An earnings date is typically considered to be the date that a company publicly announces its earnings. Many companies in the US stock market do earnings announcements once per quarter.
Earnings announcements are typically accompanied by commentary from the company that explains the earnings performance and speaks to future earnings prospects.
Earnings announcements can cause a company’s stock price to change abruptly, so earnings dates are closely monitored by some investors.
Pulmatrix Inc Earnings: Historical
| 08/13/2026 | --- | $-0.29 | --- |
| 05/19/2026 | --- | $-0.32 | --- |
| 02/26/2026 | --- | $-0.25 | --- |
| 10/16/2025 | --- | $-0.24 | --- |
| 08/06/2025 | --- | $-0.42 | --- |
| 05/15/2025 | --- | $-0.50 | --- |
| 03/26/2025 | Before Market | $-0.54 | --- |
| 11/07/2024 | Before Market | $-0.71 | --- |
| 08/13/2024 | Before Market | $-1.59 | --- |
| 05/10/2024 | Before Market | $0.23 | -1.78% |
More About Pulmatrix Inc
Pulmatrix, Inc., a biopharmaceutical company, focused on development of novel inhaled therapeutic products to prevent and treat migraine and respiratory diseases with unmet medical needs in the United States. The company offers iSPERSE, an engineered dry powder delivery platform, which enables delivery of small or large molecule drugs to the lungs by inhalation for local or systemic applications. It engages in developing PUR1800, a narrow spectrum kinase inhibitor completed Phase 1b clinical trials for the treatment of acute exacerbations in chronic obstructive pulmonary disease; PUR1900 for the treatment of allergic bronchopulmonary aspergillosis in patients with asthma and cystic fibrosis; and PUR3100, an iSPERSE formulation of dihydroergotamine which is in Phase 1 for the treatment of acute migraine. It has a license agreement with RespiVert Ltd. for access to a portfolio of kinase inhibitor compounds. The company was founded in 2003 and is headquartered in Framingham, Massachusetts.
“Pulmatrix Inc Earnings” Can Refer to the Pulmatrix Inc Earnings Date
Some people say “Pulmatrix Inc earnings” as a shortform way to refer to the earnings date.
For example, someone might say, “I plan to hold my Pulmatrix Inc position through earnings.” That typically means the person is going to hold their position through the upcoming earnings date.
Owning Pulmatrix Inc Stock on the Earnings Date
If you own Pulmatrix Inc stock (PULM) on the earnings date, then you will be exposed to the potential price volatility that often accompanies earnings announcements.
A company’s earnings typically have a big impact on its stock price, which explains why the stock price for Pulmatrix Inc might exhibit major fluctuations on the day of the earnings announcement. The price fluctuations can go in either direction (up or down), representing a larger potential investment risk and reward than many other days of the year.
There is often a big audience of investors involved with trading Pulmatrix Inc shares of stock on its earnings day. This means there is typically more trading volume, liquidity, and price volatility on the day earnings are announced.
These features are attractive to some types of active traders who are looking for stocks that exhibit large price movements and substantial volume.
Learning More Pulmatrix Inc Earnings
You can contact us any time if you would like to ask questions about Pulmatrix Inc earnings or anything else related to the stock market.